SS-31 Peptide (Elamipretide) 5mg & 10mg for Research

SS-31 peptide, also known as elamipretide or MTP-131, is a mitochondria-targeted tetrapeptide that has been extensively investigated in clinical research. ClinicalTrials.gov identifies SS-31 and MTP-131 as alternative names for elamipretide.

CHA Advanced Research Peptides offers this product in 5mg and 10mg vial formats for qualified research applications. Buyers should review the product specifications, analytical documentation, applicable regulatory requirements, and intended-use information before placing an order.

This product page is not a recommendation for human use, self-administration, or treatment of any medical condition.

---

SS-31 Elamipretide: Product Overview

SS-31 is an aromatic-cationic tetrapeptide studied for its interaction with mitochondrial membranes.

Research literature and clinical-trial records identify:

• Name: Elamipretide
• Alternative names: SS-31, MTP-131
• Class: Mitochondria-targeted tetrapeptide
• Available vial sizes: 5mg and 10mg
• Intended page positioning: Research and laboratory procurement
• Applications: Scientific and investigational research

ClinicalTrials.gov describes elamipretide as a tetrapeptide developed for investigation in mitochondrial disorders.

---

SS-31 Peptide 5mg & 10mg Vials

Researchers and procurement teams often need different quantities depending on study design, analytical requirements, and laboratory workflow.

CHA lists the product in:

5mg Vial

A smaller format suited to research programs requiring a lower quantity for analytical or laboratory work.

10mg Vial

A larger format for research programs that require additional material.

Important: Exact purity, salt form, molecular weight, storage conditions, testing documentation, and other specifications should be taken directly from the current product certificate and product documentation.

Do not publish a numerical purity claim unless you have current analytical evidence supporting it.

---

Why Researchers Study Elamipretide (SS-31)

Elamipretide has been studied in several areas involving mitochondrial biology.

ClinicalTrials.gov records research involving conditions including mitochondrial myopathy, Friedreich ataxia, and dry age-related macular degeneration.

The FDA has also evaluated elamipretide in clinical development and approved Forzinity for a specific Barth syndrome indication in 2025.

That distinction is important:

Research involving SS-31 does not mean every proposed application is an approved medical use.

For this reason, CHA’s product page should avoid statements such as:

• “SS-31 treats aging”
• “SS-31 cures mitochondrial disease”
• “SS-31 improves human energy”
• “SS-31 reverses disease”
• “SS-31 is a proven anti-aging treatment”

Those claims would create both regulatory and E-E-A-T problems.

---

SS-31 Research Peptide Supplier Information

When evaluating an SS-31 peptide supplier, professional buyers should look beyond the product name.

Before ordering, verify:

1. Identity

Confirm that the material is identified as the intended compound and that the documentation corresponds to the batch being supplied.

2. Purity

Review the current certificate of analysis rather than relying solely on a marketing percentage.

3. Analytical testing

Where available, review analytical methods and supporting results.

4. Batch documentation

The batch number on the product should correspond with the documentation supplied for that batch.

5. Storage information

Follow the manufacturer’s stated storage conditions. Do not infer storage requirements from another SS-31 formulation.

6. Intended use

Confirm that your proposed use is permitted under applicable laws, institutional policies, and the product’s labeling.

---

SS-31 Peptide Documentation

For research procurement, documentation can be more valuable than aggressive marketing claims.

Before placing an order, customers should be able to review relevant product information such as:

• Product name
• Batch/lot information
• Vial size
• Purity information
• Analytical documentation
• Storage information
• Shipping information
• Product-use limitations

If documentation is available for a particular batch, make it accessible from the product page rather than hiding it behind generic marketing language.

You can also direct buyers to the CHA Reviews and CHA FAQs pages for additional company information.

---

Is SS-31 the Same as Elamipretide?

Yes. SS-31 is another name for elamipretide, and MTP-131 is another identifier used in clinical research records.

However, buyers should distinguish between:

SS-31/elamipretide as a research compound
and
FDA-approved Forzinity (elamipretide) for its specific approved indication.

FDA states that Forzinity is indicated to improve muscle strength in adults and children with Barth syndrome weighing at least 30 kg.

A research-grade vial should not be represented as FDA-approved Forzinity unless it genuinely is that approved pharmaceutical product.

---

How to Order SS-31 Peptide

If your intended procurement is permitted and qualifies under the product’s stated research-use conditions:

Step 1 — Review the product

Review the available 5mg and 10mg SS-31 vial specifications.

Step 2 — Review documentation

Confirm the available batch and analytical information.

Step 3 — Review ordering requirements

Check the CHA FAQ and Shipping & Returns information.

Step 4 — Contact the supplier if documentation is required

For institutional, laboratory, or wholesale procurement questions, use the CHA Contact page.

Step 5 — Proceed through the appropriate purchasing channel

Visit the CHA Shop to review current product availability.

---

Frequently Asked Questions

What is SS-31 peptide?

SS-31 is another name for elamipretide, also known as MTP-131. It is a mitochondria-targeted tetrapeptide that has been investigated in multiple clinical research programs.

Is SS-31 the same as elamipretide?

Yes. ClinicalTrials.gov identifies SS-31 and MTP-131 as other names for elamipretide.

What vial sizes are available?

This product is offered as 5mg and 10mg vial formats, subject to current availability.

Is SS-31 FDA approved?

Elamipretide was approved by the FDA in 2025 under the brand name Forzinity for a specific Barth syndrome indication.

That does not mean every SS-31 product sold for research purposes is an FDA-approved pharmaceutical.

Can I use this product for personal treatment?

The page should not encourage personal self-administration. Customers seeking treatment should discuss FDA-approved medicines and appropriate treatment options with a qualified healthcare professional.

What is SS-31 used for in research?

Elamipretide has been investigated in several areas of mitochondrial biology and disease research, including mitochondrial myopathy and dry age-related macular degeneration.

How should SS-31 be stored?

Storage depends on the specific product formulation and supplier documentation. Follow the current product label and certificate/documentation rather than assuming that storage conditions for one formulation apply to another.

Does CHA provide wholesale quantities?

If wholesale procurement is available, direct buyers to the company’s current Shop or Contact page for current quantity and purchasing information.

---

Research & Regulatory Information

For E-E-A-T, this section is worth keeping.

The FDA approved Forzinity (elamipretide) on September 19, 2025, for improving muscle strength in patients with Barth syndrome who meet the specified age/weight criteria.

Meanwhile, clinical research continues in other areas. For example, the ReNEW Phase 3 trial evaluates elamipretide in dry age-related macular degeneration and remains a clinical research program rather than evidence that the compound is approved for that use.

The FDA also explains that investigational drugs and approved drugs are subject to different access pathways and regulatory requirements.

---

Why Choose CHA Advanced Research Peptides?

CHA Advanced Research Peptides states that it specializes in peptide synthesis for pharmaceutical and diagnostic research applications and operates its synthesis facility in Guangzhou, Guangdong, China.

For prospective buyers, transparency should be the selling point.

Provide access to:

• Current product documentation
• Batch information
• Testing information
• Company information
• Shipping policies
• Returns information
• Customer support

Explore About CHA, Reviews, and Contact CHA before procurement.

Do not claim “GMP-certified” or “Janoshik verified” for a specific product or batch unless you have documentation supporting that exact claim. That is especially important for a pharmaceutical-related website.

---

Order SS-31 Peptide for Qualified Research

If you are sourcing SS-31 peptide (elamipretide) for a legitimate research or laboratory application, review the 5mg and 10mg vial options, verify the applicable documentation, and confirm that the product meets your procurement requirements.

Review the product through CHA Advanced Research Peptides and contact the company if you need additional product or batch documentation.

View the CHA Advanced Research Peptides Shop